251 related articles for article (PubMed ID: 21466427)
21. Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies.
Kaps A; Gwiazdoń P; Chodurek E
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801096
[TBL] [Abstract][Full Text] [Related]
22. Effect of triterpenoids on the inflammation induced by protein kinase C activators, neuronally acting irritants and other agents.
Huguet A; del Carmen Recio M; Máñez S; Giner R; Ríos J
Eur J Pharmacol; 2000 Dec; 410(1):69-81. PubMed ID: 11134658
[TBL] [Abstract][Full Text] [Related]
23. Ursolic acid: an anti- and pro-inflammatory triterpenoid.
Ikeda Y; Murakami A; Ohigashi H
Mol Nutr Food Res; 2008 Jan; 52(1):26-42. PubMed ID: 18203131
[TBL] [Abstract][Full Text] [Related]
24. Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.
Yadav VR; Prasad S; Sung B; Kannappan R; Aggarwal BB
Toxins (Basel); 2010 Oct; 2(10):2428-66. PubMed ID: 22069560
[TBL] [Abstract][Full Text] [Related]
25. Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs.
Safe SH; Prather PL; Brents LK; Chadalapaka G; Jutooru I
Anticancer Agents Med Chem; 2012 Dec; 12(10):1211-20. PubMed ID: 22583404
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives.
Markov AV; Zenkova MA; Logashenko EB
Curr Med Chem; 2017; 24(13):1277-1320. PubMed ID: 28078994
[TBL] [Abstract][Full Text] [Related]
27. Cancer chemopreventive activity of oleanane-type triterpenoids from the stem bark of Betula ermanii.
Yamaguchi C; In Y; Wada S; Yamada T; Tokuda H; Tanaka R
Chem Biodivers; 2009 Jul; 6(7):1093-100. PubMed ID: 19623559
[TBL] [Abstract][Full Text] [Related]
28. Oleanolic acid and related triterpenoids from olives on vascular function: molecular mechanisms and therapeutic perspectives.
Rodriguez-Rodriguez R
Curr Med Chem; 2015; 22(11):1414-25. PubMed ID: 25515513
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor promoting effects of multiflorane-type triterpenoids and cytotoxic activity of karounidiol against human cancer cell lines.
Akihisa T; Tokuda H; Ichiishi E; Mukainaka T; Toriumi M; Ukiya M; Yasukawa K; Nishino H
Cancer Lett; 2001 Nov; 173(1):9-14. PubMed ID: 11578803
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.
Konoshima T; Takasaki M; Tatsumoto T; Kozuka M; Kasai R; Tanaka O; Nie RL; Tokuda H; Nishino H; Iwashima A
Biol Pharm Bull; 1994 May; 17(5):668-71. PubMed ID: 7920430
[TBL] [Abstract][Full Text] [Related]
31. Structural requirements for the anti-inflammatory activity of natural triterpenoids.
Recio MC; Giner RM; Máñez S; Ríos JL
Planta Med; 1995 Apr; 61(2):182-5. PubMed ID: 7753929
[TBL] [Abstract][Full Text] [Related]
32. Pentacyclic triterpenoids and their saponins with apoptosis-inducing activity.
Wang SR; Fang WS
Curr Top Med Chem; 2009; 9(16):1581-96. PubMed ID: 19903161
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Alpha-Glucosidase by Synthetic Derivatives of Lupane, Oleanane, Ursane and Dammarane Triterpenoids.
Khusnutdinova EF; Smirnova IE; Giniyatullina GV; Medvedeva NI; Yamansarov EY; Kazakov DV; Kazakova OB; Linh PT; Viet do Q; Huong DT
Nat Prod Commun; 2016 Jan; 11(1):33-5. PubMed ID: 26996014
[TBL] [Abstract][Full Text] [Related]
34. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
35. Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway.
Hajra S; Patra AR; Basu A; Saha P; Bhattacharya S
Chem Biol Interact; 2018 Jun; 290():19-36. PubMed ID: 29775573
[TBL] [Abstract][Full Text] [Related]
36. Tumor inflammatory angiogenesis and its chemoprevention.
Albini A; Tosetti F; Benelli R; Noonan DM
Cancer Res; 2005 Dec; 65(23):10637-41. PubMed ID: 16322203
[TBL] [Abstract][Full Text] [Related]
37. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview.
Ovesná Z; Vachálková A; Horváthová K; Tóthová D
Neoplasma; 2004; 51(5):327-33. PubMed ID: 15640935
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of pentacyclic triterpenoids from Astilbe rivularis on TGFBIp-induced inflammatory responses in vitro and in vivo.
Jung B; Chung J; Zhou W; Lee T; Na M; Bae JS
Chem Biol Interact; 2016 Jul; 254():179-90. PubMed ID: 27287417
[TBL] [Abstract][Full Text] [Related]
39. Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases.
Patel SM; Nagulapalli Venkata KC; Bhattacharyya P; Sethi G; Bishayee A
Semin Cancer Biol; 2016 Oct; 40-41():100-115. PubMed ID: 27019417
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill.
Wang G; Wang YZ; Yu Y; Wang JJ
J Ethnopharmacol; 2019 May; 235():255-267. PubMed ID: 30772482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
